scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0306-4522(99)00244-4 |
P698 | PubMed publication ID | 10501466 |
P2093 | author name string | Wang R | |
Mazzarelli L | |||
Anderson JJ | |||
Holtz G | |||
Wagner SL | |||
Baskin PP | |||
Menzaghi F | |||
P2860 | cites work | Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 |
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
Place navigation impaired in rats with hippocampal lesions | Q29547869 | ||
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids | Q34255552 | ||
Hippocampal representation in place learning. | Q34635657 | ||
Loss of perforated synapses in the dentate gyrus: morphological substrate of memory deficit in aged rats | Q35603350 | ||
Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor | Q35638734 | ||
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease | Q36415791 | ||
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity | Q36415795 | ||
Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. | Q36530142 | ||
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation | Q36548591 | ||
Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients | Q36908767 | ||
Altered levels of amyloid protein precursor transcripts in the basal forebrain of behaviorally impaired aged rats | Q37739715 | ||
Normal aging: regionally specific changes in hippocampal synaptic transmission | Q40387599 | ||
Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory. | Q40476298 | ||
Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain | Q41156869 | ||
Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury | Q41451125 | ||
Life and death of neurons in the aging brain | Q41614205 | ||
Cleavage of amyloid beta peptide during constitutive processing of its precursor | Q41852594 | ||
Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing | Q45039717 | ||
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors | Q46046983 | ||
Reduction of neurological damage by a peptide segment of the amyloid beta/A4 protein precursor in a rabbit spinal cord ischemia model | Q46736730 | ||
Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain | Q48142042 | ||
Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to behavioral measures of age-related cognitive dysfunction | Q48144133 | ||
Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats | Q48157101 | ||
Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach | Q48331232 | ||
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein | Q48342880 | ||
Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. | Q48505477 | ||
Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation | Q48719353 | ||
Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the rat. | Q48932605 | ||
Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. | Q53199638 | ||
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. | Q53200377 | ||
Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas | Q53200551 | ||
A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat | Q71678874 | ||
Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats | Q71923911 | ||
An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid | Q72250034 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebrospinal fluid | Q54196 |
spatial memory | Q3560550 | ||
P304 | page(s) | 1409-1420 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits | |
P478 | volume | 93 |
Q40841974 | A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model |
Q34243604 | A plausible function of the prion protein: conjectures and a hypothesis |
Q35019451 | Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. |
Q48444707 | Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity. |
Q43655573 | Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats |
Q34126136 | Animal models of Alzheimer's disease and evaluation of anti-dementia drugs |
Q34521275 | Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats |
Q36089364 | Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease |
Q40819093 | Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains |
Q33622388 | Comparative analysis of single and combined APP/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPsα expression |
Q54234721 | Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. |
Q48021355 | Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9. |
Q50094019 | Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease |
Q73398033 | Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients |
Q34508624 | Modeling Alzheimer's disease in transgenic rats |
Q39209681 | Not just amyloid: physiological functions of the amyloid precursor protein family |
Q26738884 | Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease |
Q38929253 | Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease. |
Q89747430 | Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease |
Q28202553 | Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory |
Q36503175 | The effect of stress on the expression of the amyloid precursor protein in rat brain |
Q27026919 | The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes |
Q40106778 | The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. |
Q39145999 | Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα. |
Q40354888 | Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model. |
Q50706672 | sAβPPα Improves Hippocampal NMDA-Dependent Functional Alterations Linked to Healthy Aging. |
Search more.